- Supported exchanges /
- NASDAQ /
- SEPN.NASDAQ
Septerna, Inc. Common Stock (SEPN NASDAQ) stock market data APIs
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products candidates for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. The company develops SEP-786, an oral small molecule PTH1R agonist for hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 NAM for chronic spontaneous urticaria and other mast cell diseases; TSHR Program, an oral small molecule TSHR NAM for Graves' disease and thyroid eye disease. It also develops oral small molecule single- and multi-incretin receptor agonists for metabolic disorders including obesity and type 2 diabetes. Septerna, Inc. was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. The company was incorporated in 2019 and is headquartered in South San Francisco, California.
Septerna, Inc. Common Stock Financial Data Overview
| 25.9 | |
| 27.21 | |
| - | |
| 27.57 | |
| 24.8 | |
| 18-28.99 | |
| 0 | |
| 0 | |
| 0 | |
| -0.4622 | |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Septerna, Inc. Common Stock Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA 0
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Septerna, Inc. Common Stock Earnings via APIs
- Latest Release 2024-11-20
- EPS/Forecast NaN
Get Septerna, Inc. Common Stock End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
